Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?

Symptomatic intracranial atherosclerotic disease (ICAD) is a globally challengeable disease. In the past 20 years, people have made a huge effort to deal with the problem including using endovascular technology and aggressive medical therapy. However, the efficacy of these methods seemed to be limit...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Fang, Yun, Ho Jun, Peng, Liwei, Wu, Chuanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158658/
https://www.ncbi.nlm.nih.gov/pubmed/37151789
http://dx.doi.org/10.4103/bc.bc_68_22
_version_ 1785036974619361280
author Xue, Fang
Yun, Ho Jun
Peng, Liwei
Wu, Chuanjie
author_facet Xue, Fang
Yun, Ho Jun
Peng, Liwei
Wu, Chuanjie
author_sort Xue, Fang
collection PubMed
description Symptomatic intracranial atherosclerotic disease (ICAD) is a globally challengeable disease. In the past 20 years, people have made a huge effort to deal with the problem including using endovascular technology and aggressive medical therapy. However, the efficacy of these methods seemed to be limited. The recent China angioplasty and stenting for symptomatic intracranial severe stenosis (CASSISS) did not support the addition of percutaneous transluminal angioplasty and stenting to medical therapy for the treatment of patients with symptomatic severe ICAD. So where are we heading in the post-CASSISS era?
format Online
Article
Text
id pubmed-10158658
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-101586582023-05-05 Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era? Xue, Fang Yun, Ho Jun Peng, Liwei Wu, Chuanjie Brain Circ Perspective Symptomatic intracranial atherosclerotic disease (ICAD) is a globally challengeable disease. In the past 20 years, people have made a huge effort to deal with the problem including using endovascular technology and aggressive medical therapy. However, the efficacy of these methods seemed to be limited. The recent China angioplasty and stenting for symptomatic intracranial severe stenosis (CASSISS) did not support the addition of percutaneous transluminal angioplasty and stenting to medical therapy for the treatment of patients with symptomatic severe ICAD. So where are we heading in the post-CASSISS era? Wolters Kluwer - Medknow 2023-03-24 /pmc/articles/PMC10158658/ /pubmed/37151789 http://dx.doi.org/10.4103/bc.bc_68_22 Text en Copyright: © 2023 Brain Circulation https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Perspective
Xue, Fang
Yun, Ho Jun
Peng, Liwei
Wu, Chuanjie
Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?
title Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?
title_full Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?
title_fullStr Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?
title_full_unstemmed Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?
title_short Where are we heading in post-China angioplasty and stenting for symptomatic intracranial severe stenosis era?
title_sort where are we heading in post-china angioplasty and stenting for symptomatic intracranial severe stenosis era?
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158658/
https://www.ncbi.nlm.nih.gov/pubmed/37151789
http://dx.doi.org/10.4103/bc.bc_68_22
work_keys_str_mv AT xuefang whereareweheadinginpostchinaangioplastyandstentingforsymptomaticintracranialseverestenosisera
AT yunhojun whereareweheadinginpostchinaangioplastyandstentingforsymptomaticintracranialseverestenosisera
AT pengliwei whereareweheadinginpostchinaangioplastyandstentingforsymptomaticintracranialseverestenosisera
AT wuchuanjie whereareweheadinginpostchinaangioplastyandstentingforsymptomaticintracranialseverestenosisera

Ejemplares similares